Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Thyrocare shares picked up in bulk deals as labs become testing centres for covid

 Nalanda India Fund bought shares of Thyrocare shares in two bulk deals, of 1.7 million shares and 1.09 million shares each. Thyrocare Technologies has seen its share price rise over the past week, as well as higher delivery volumes as the company emerged as one of the lab companies approved for coronavirus testing - ICMR has so far given Thyrocare's lab in Navi Mumbai recognized status for coronavirus tests. It is one of nine labs in Mumbai that will be testing coronavirus cases. While the government has capped price of tests at Rs. 4,500, emerging cheaper Made in India test kits have made potential margins possible for the firm as it scales up tests for patients.
26-03-2020
Bigul

Metropolis, Thyrocare say they will start tests for coronavirus from today

 They would start collecting samples for testing from today. For starters, this would happen in Mumbai
23-03-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 --o-- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Con-call has been arranged by PhillipCapital (India) Pvt. Ltd. with Dr. A. Velumani, Chairman, Managing Director and CEO of our company, to discuss on Covid-19 and its impact on Indian Healthcare, at 02.30 P.M. today, i.e. Wednesday, March 18, 2020. The con-call arranged through Prabhudas Lilladher Pvt. Ltd. on the same topic has been deferred. Please note that this is subject to any last minute changes.
18-03-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that we would be having a Con-call with the representative(s) of Prabhudas Lilladher (P) Limited, at 04.00 P.M. today, i.e. Wednesday, March 18, 2020. Please note that this is subject to any last minute changes.
18-03-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of Crescita Investment Management Pvt. Ltd. would be having a meeting with us at 04.00 P.M. on Wednesday, March 11, 2020 at the Corporate Office of the Company. Please note that this is subject to any last minute changes.
09-03-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings to be held at the Corporate Office of the Company: i) Meeting with the representative(s) of J. P. Morgan India Private Limited, at 11.30 A.M. on Wednesday, March 11, 2020. ii) Meeting with the representative(s) of Aditya Birla Capital, at 11.00 A.M. on Thursday, March 12, 2020. iii) Meeting with the representative(s) of Hill Fort Capital Partners Limited, at 11.30 A.M. on Wednesday, March 18, 2020. Please note that these meetings are subject to any last minute changes.
07-03-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings to be held at the Corporate Office of the Company: i) Meeting with the representative(s) of QRC Investment Advisors LLP, at 11.30 A.M. on Monday, February 24, 2020. ii) Meeting with the representative(s) of SBI Mutual Fund, at 3.00 P.M. on Monday, February 24, 2020. iii) Meeting with the representative(s) of Ampersand Capital Partners, at 11.30 A.M. on Tuesday, February 25, 2020. iv) Meeting with the representative(s) of Wallfort Financial Services Limited, at 4.00 P.M. on Tuesday, February 25, 2020. Please note that these meetings are subject to any last minute changes.
22-02-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 We wish to intimate that we, as a leading provider of wellness tests, are launching Blood-based Cancer Screening Profile. This consists of Easycheck360TM, a cancer screening test profile for early detection of 16 types of cancers, processed by Datar Cancer Genetics. In this regard, we are forwarding a Press Release, announcing the launching of this impactful profile, in association with Datar Cancer Genetics. This is for the information of the investors and general public. This press release is also being made available on the website of the Company at www.thyrocare.com This is for your information
17-02-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the forthcoming Con-call to be held as follows; i) Con-call with the representative(s) of Eternity Capital Management Limited, at 11.00 A.M. on Monday, February 17, 2020. ii) Con-call with the representative(s) of Mirabilis Investment Trust, at 04.00 P.M. on Monday, February 17, 2020. Please note that these are subject to any last minute changes.
15-02-2020
Bigul

Thyrocare Technologies hits 52-week high, surges 28% in two days

 The company's normalized Ebitda grew 19 per cent year on year (YoY) at Rs 42.5 crore, while margins improved to 40 per cent compared with 37 per cent clocked in the previous year quarter
04-02-2020
Next Page
Close

Let's Open Free Demat Account